For the latest onThailand Medical Industry, Thailand Doctors, Thailand Medical Research, Thailand Hospitals, Thailand Wellness Initiatives and the latest Medical News

BREAKING NEWS
Nikhil Prasad  Fact checked by:Thailand Medical News Team Jan 30, 2026  2 weeks, 3 days, 14 hours, 53 minutes ago

Cholesterol Pathways Open New Doors in Cancer Therapy

3522 Shares
facebook sharing button Share
twitter sharing button Tweet
linkedin sharing button Share
Cholesterol Pathways Open New Doors in Cancer Therapy
Nikhil Prasad  Fact checked by:Thailand Medical News Team Jan 30, 2026  2 weeks, 3 days, 14 hours, 53 minutes ago
Medical News: A growing body of research is changing how scientists understand cholesterol, a substance long linked mainly to heart disease. New findings now show that cholesterol also plays a powerful role in helping cancer grow, spread, and resist treatment. This shift in thinking could open the door to a new generation of cancer therapies aimed at cutting off tumors’ cholesterol supply.


New research reveals how targeting cholesterol pathways may transform future cancer treatments

Why Cholesterol Matters in Cancer
Cholesterol is an essential building block for healthy cells. It helps maintain cell membranes and supports hormone production. However, cancer cells appear to hijack this normal process. The new research explains that cancer cells often increase their cholesterol intake or production to fuel rapid growth. High cholesterol inside tumor cells helps them build new membranes, activate growth signals, and survive in hostile environments.
 
Key Biological Pathways Under the Spotlight
The study focuses on several cholesterol-related pathways that appear especially important in cancer. One major player is SREBP2, a protein that acts like a master switch for cholesterol production. When activated, it pushes cancer cells to make more cholesterol, supporting tumor growth. Another important protein, SOAT1, helps store excess cholesterol inside cancer cells, preventing toxic buildup while still keeping a steady supply available.
 
Researchers also highlighted the role of NPC1, a protein that moves cholesterol within cells, and PCSK9, which controls how much cholesterol cancer cells pull in from the bloodstream. Together, these pathways create a cholesterol-rich environment that allows tumors to thrive.
 
What The Researchers Found
By reviewing years of laboratory and clinical data, the scientists showed that disrupting cholesterol metabolism can slow cancer growth in multiple cancer types, including breast, prostate, liver, and colon cancers. Blocking these cholesterol pathways reduced cancer cell survival, interfered with tumor signaling, and, in some cases, made cancer cells more sensitive to existing treatments. This Medical News report highlights that some drugs already used for cholesterol control, such as statins or PCSK9 inhibitors, may have untapped potential in cancer therapy.
 
Boosting The Immune System Against Cancer
An important and hopeful finding involves the immune system. Excess cholesterol inside immune cells can make them tired and less effective. By carefully adjusting cholesterol metabolism, immune cells such as T-cells may regain strength, improving the effectiveness of immunotherapies like CAR-T treatments. This suggests cholesterol-targeting strategies could work alongside modern cancer immunotherapy.
 
Where The Research Was Conducted
The research involved scientists from West China Hospital of Sichuan University and the Sichuan Academy of Chinese Medicine Sciences in China; Amity Univ ersity and Lovely Professional University in India; Marwadi University and JAIN University in India; NIMS University Rajasthan in India; Chandigarh Group of Colleges in India; Prince Sattam Bin Abdulaziz University in Saudi Arabia; and Lake Erie College of Osteopathic Medicine in the United States.
 
Conclusions And Future Outlook
The findings strongly suggest that cholesterol is far more than a background player in cancer. It actively shapes how tumors grow, spread, and evade treatment. By targeting cholesterol pathways such as SREBP2, SOAT1, NPC1, and PCSK9, future therapies could weaken cancer cells while strengthening immune responses. Although more clinical trials are needed, this approach offers a promising and practical direction for developing safer, more effective cancer treatments.
 
The study findings were published in the peer reviewed journal: Cancers.
https://www.mdpi.com/2072-6694/18/3/428
 
For the latest cancer research, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/articles/cancer
 

MOST READ

Feb 12, 2026  5 days ago
Nikhil Prasad
Feb 11, 2026  6 days ago
Nikhil Prasad
Feb 09, 2026  8 days ago
Nikhil Prasad
Feb 08, 2026  8 days ago
Nikhil Prasad
Feb 08, 2026  8 days ago
Nikhil Prasad
Feb 06, 2026  11 days ago
Nikhil Prasad
Feb 04, 2026  12 days ago
Nikhil Prasad
Feb 02, 2026  15 days ago
Nikhil Prasad
Feb 01, 2026  16 days ago
Nikhil Prasad
Jan 31, 2026  17 days ago
Nikhil Prasad
Jan 27, 2026  20 days ago
Nikhil Prasad
Jan 27, 2026  21 days ago
Nikhil Prasad
Jan 26, 2026  21 days ago
Nikhil Prasad
Jan 25, 2026  23 days ago
Nikhil Prasad
Jan 24, 2026  24 days ago
Nikhil Prasad
Jan 23, 2026  25 days ago
Nikhil Prasad
Jan 22, 2026  25 days ago
Nikhil Prasad
Jan 21, 2026  27 days ago
Nikhil Prasad

FROM SUPPLEMENTS

LATEST ON PR RELEASES